Sugi Predict

Sugi Predict / Compounds / SCHEMBL190973

SCHEMBL190973

SCHEMBL190973

CCOC(=O)c1cnc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 1/20 0.51
▸ BAZ2A Q9UIF9 1/20 0.51
▸ HPGD P15428 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ CYP4F2 P78329 1/20 0.48
▸ CYP4A11 Q02928 1/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA12 O43570 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29574609 1.00 BAZ2B (0.51) BAZ2BBAZ2AHPGDALDH1A1MAPT
SCHEMBL3516119 0.88 BAZ2B (0.49) BAZ2BBAZ2AHPGDALDH1A1MAPT
SCHEMBL6134191 0.87 CYP4F2 (0.51) BAZ2BBAZ2AHPGDALDH1A1MAPT
SCHEMBL3652621 0.87 BAZ2B (0.51) BAZ2BBAZ2AHPGDALDH1A1MAPT
SCHEMBL31368185 0.87 CYP4F2 (0.51) BAZ2BBAZ2AHPGDALDH1A1MAPT
SCHEMBL13982866 0.87 DGAT1 (0.49) BAZ2BBAZ2AHPGDALDH1A1CYP4F2
SCHEMBL24341947 0.85 KMT2A (0.46) BAZ2BBAZ2AHPGDALDH1A1CYP4F2
SCHEMBL29557951 0.85 KMT2A (0.46) BAZ2BBAZ2AHPGDALDH1A1CYP4F2
SCHEMBL7855992 0.85 CA12 (0.53) HPGDALDH1A1MAPTTDP1KMT2A
SCHEMBL20489593 0.84 DPP4 (0.48) HPGDALDH1A1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1010 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651241-A A kind of synthetic method of the bromo- 6- chlorine cigarette aldehyde of 4- 上海毕得医药技术有限公司 2019-04-19 — — CN claimed
CN-109281171-A A kind of preparation method of the anti-breaking silk weaving with coating 安徽省永欣织带有限公司 2019-01-29 — — CN claimed
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 — — WO disclosed
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2026-05-12 — — US disclosed
EP-4393921-B1 NALIDINONE COMPOUND AS FGFR4 INHIBITOR AND USE THEREOF UNIV WENZHOU MEDICAL (CN) 2026-04-15 — — EP disclosed
US-12600709-B2 Nonpeptide somatostatin type 5 receptor agonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2026-04-14 — — US disclosed
US-12595245-B2 Inhibitors of MET kinase CELYN THERAPEUTICS, INC. (US) 2026-04-07 — — US disclosed
EP-4051677-B1 BICYCLIC NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF SALT-INDUCED KINASE SIK2 CANCER RESEARCH TECH LTD (GB) 2026-03-18 — — EP disclosed
US-20260055121-A1 TYK2 INHIBITORS AND USES THEREOF SUDO BIOSCIENCES LTD (GB) 2026-02-26 — — US disclosed
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 — — US disclosed
EP-4688772-A1 BIARYL DERIVATIVES AND RELATED USES Moma Therapeutics, Inc. (US) 2026-02-11 — — EP disclosed
EP-0700399-B1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS LEPETIT SPA (IT) 2001-10-04 — — EP disclosed
EP-1136492-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-26 — — EP disclosed
WO-2000050398-A2 PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-08-31 — — WO disclosed
US-5786350-A CONDENSATION; HYDROLYSIS; DEPROTECTING GRUPPO LEPETIT S.P.A. (IT) 1998-07-28 — — US disclosed
EP-0700399-A1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS GRUPPO LEPETIT S.P.A. (IT) 1996-03-13 — — EP disclosed
WO-1994028002-A1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS GRUPPO LEPETIT S.P.A. (IT) 1994-12-08 — — WO disclosed
US-5077429-A 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-QUINOLINE- AND NAPHTHYRIDINE-3-CARBOXYLIC ACIDS, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THESE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1991-12-31 — — US disclosed
US-4670444-A 7-amino-1-cyclopropyl-4-oxo-1, 4-dihydro-quinoline-and naphthyridine-3-carboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
US-4620007-A BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1986-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 BAZ2B 301/4885BAZ2A 234/4885HPGD 1019/4885
US-12595245-B2 Inhibitors of MET kinase MET, ABL1, ERBB2 BAZ2B 1160/4885BAZ2A 1121/4885HPGD 4117/4885
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 BAZ2B 1876/4885BAZ2A 1805/4885HPGD 3825/4885
US-12600709-B2 Nonpeptide somatostatin type 5 receptor agonists and uses thereof SSTR5, SSTR4, GLP1R BAZ2B 3906/4885BAZ2A 3911/4885HPGD 4441/4885
US-20260055121-A1 TYK2 INHIBITORS AND USES THEREOF TYK2, CSNK2A3, CSNK2B BAZ2B 484/4885BAZ2A 458/4885HPGD 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.